Showing 1 - 2 results of 2 for search 'Rachel M Koldej', query time: 0.01s Refine Results
  1. 1
    Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study

    Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study by Allison Barraclough, Sze Ting Lee, Melinda Burgess, Leonid Churilov, Geoff Chong, Denise Lee, Michael Gilbertson, Tineke Fancourt, Kate Manos, David S. Ritchie, Rachel M. Koldej, Andrew M. Scott, Colm Keane, Eliza A. Hawkes

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals

    Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals by Palak H Mehta, Gemma S Trollope, Patrick Leung, Shivali Savita Chinni, Anna Iasinskaia, Aaron J Harrison, Hannah Hughes‐Parry, Misty R Jenkins, Michael H Kershaw, Anthony Jaworowski, Clare Y Slaney, Rachel M Koldej, David S Ritchie, Kylie M Quinn

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: